|Articles|February 1, 2018
- Pharmaceutical Executive-02-01-2018
- Volume 38
- Issue 2
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Pharma's Image Fix: Lessons from the Fieldalmost 8 years ago
The Innovation Distinction: Biopharma's Reputational Passalmost 8 years ago
Valeant’s Northern Facealmost 8 years ago
More New Drugs and Generics Reshape Pharma Marketsalmost 8 years ago
Leadership in All the Right Placesalmost 8 years ago
Industry Engine CheckNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
